Carregant...

Adjunctive perampanel for refractory partial-onset seizures: Randomized phase III study 304

OBJECTIVE: To assess efficacy and safety of once-daily 8 or 12 mg perampanel, a noncompetitive α-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) receptor antagonist, when added to concomitant antiepileptic drugs (AEDs) in the treatment of drug-resistant partial-onset seizures. METHODS: Th...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: French, Jacqueline A., Krauss, Gregory L., Biton, Victor, Squillacote, David, Yang, Haichen, Laurenza, Antonio, Kumar, Dinesh, Rogawski, Michael A.
Format: Artigo
Idioma:Inglês
Publicat: Lippincott Williams & Wilkins 2012
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3413761/
https://ncbi.nlm.nih.gov/pubmed/22843280
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0b013e3182635735
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!